דיקלופלסט इसराइल - हिब्रू - Ministry of Health

דיקלופלסט

cts ltd - diclofenac sodium - מדבקות - diclofenac sodium 140 mg - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

פן-סטרפ 20/25 וטרינרי इसराइल - हिब्रू - Ministry of Health

פן-סטרפ 20/25 וטרינרי

abic veterinary products ltd - dehydrostreptomycin sulfate 250 mg/ml; procaine benzylpenicillin 200 iu/ml - solution for injection - infections due to penicillin and streptomycin sensitive microorganism.

פן וסטרפ וטרינרי इसराइल - हिब्रू - Ministry of Health

פן וסטרפ וטרינרי

comex ltd - dihydrostreptomycin sulfate 250 mg/ml; procaine benzylpenicillin 200 mg/ml - suspension for injection - treatment of infection caused orassociated with organisms sensitive to penicillin and/or streptomycin in cattle, horses, pigs and sheep.

נורוצילין וטרינרי इसराइल - हिब्रू - Ministry of Health

נורוצילין וטרינרי

comex ltd - procaine benzylpenicillin 300 mg/ml - suspension for injection - norocillin is recommended in the treatment of diseases caused by susceptible organisms to penicillin in cattle, sheep and pigs.

דיפרוספאן זריקה इसराइल - हिब्रू - Ministry of Health

דיפרוספאן זריקה

organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.

ונטולין סירופ इसराइल - हिब्रू - Ministry of Health

ונטולין סירופ

glaxo smith kline (israel) ltd - salbutamol as sulfate - סירופ - salbutamol as sulfate 2 mg / 5 ml - salbutamol - salbutamol - relief of bronchospasm in bronchial asthma of all types,chronic bronchitis,efmphysema.

נוקספיל תרחיף इसराइल - हिब्रू - Ministry of Health

נוקספיל תרחיף

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

נוקספיל תרחיף इसराइल - हिब्रू - Ministry of Health

נוקספיל תרחיף

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

אייבו % 4 לילדים इसराइल - हिब्रू - Ministry of Health

אייבו % 4 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 40 mg/ml - ibuprofen

אייבו % 4 לילדים इसराइल - हिब्रू - Ministry of Health

אייבו % 4 לילדים

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 200 mg / 5 ml - ibuprofen